Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q1 2017 13F Holders as of 31 Mar 2017
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 10,076,433
- Total 13F value
- $40,304,200
- Share change
- -416,573
- SEC-reported price per share
- $4.00
- Number of holders
- 37
- Value change
- -$3,171,773
- Number of buys
- 14
- Number of sells
- 17
- Shares outstanding
- 92,799,600
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2017
Institutions
37
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F
Lead comparable stake: 3.3%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 3.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
3.3%
Capital World Investors
1.3%
ORBIMED ADVISORS LLC
1.1%
PERCEPTIVE ADVISORS LLC
0.8%
Tekla Capital Management LLC
0.75%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
3.3%
|
$23,437,000
3,043,805 shares
|
— | 31 Dec 2016 |
| Capital World Investors |
13F
Company
|
1.3%
|
$9,433,000
1,225,000 shares
|
— | 31 Dec 2016 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.1%
|
$7,700,000
1,000,000 shares
|
— | 31 Dec 2016 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
0.8%
|
$5,700,000
740,272 shares
|
— | 31 Dec 2016 |
| Tekla Capital Management LLC |
13F
Company
|
0.75%
|
$5,390,000
700,000 shares
|
— | 31 Dec 2016 |
| DAFNA Capital Management LLC |
13F
Company
|
0.55%
|
$3,959,000
514,091 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
37
Shares
10,076,433
Rows available
37
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q1 2017 Across Filers
Q1 2017 holders
37
Q1 2017 holders
37
Holder diff
0
| Investor | Q1 2017 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend